Alkem

For the 12 months through Mar’24, IPM grew 7.6 per cent YoY and prices/volume/new launches increased by 4.0 per cent/0.7 per…

Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient groups…

Cetuximab is a therapeutic chimeric monoclonal antibody that is used as a targeted therapy for metastatic colorectal cancer (mCRC)…

In response to Form 483 issued by the US FDA containing one observation, the company had submitted a detailed CAPA plan to the…

This is in line with company’s endeavour to ensure affordability, accessibility and availability while saving the lives of…

The drug comes in capsule form in multiple dose strengths with varied pricing ranges, including 125 mg at Rs 6,125/- for 21…

Express Pharma, in association with SAP India, as part of the Life Sciences Industry Knowledge Exchange Forum, recently hosted a…

Brivaracetam has shown promise in patients with epilepsy whose seizures persist despite adequate treatment.

Favipiravir is approved by the DCGI restricted emergency use in India for the treatment of mild to moderate cases of COVID-19

The sudden change in preferred therapies by masses has just taken a sharp turn from pre-COVID period when gastric, vitamin…